Cerebrospinal Fluid in Pediatric Neuro-Oncology: Molecular Diagnosis, Disease Monitoring, and Clinical Translation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27115010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Aidos Bolatov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineer…. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Pediatric brain and other central nervous system (CNS) tumors remain a leading cause of cancer-related death in children, while contemporary management increasingly depends on molecular classification, risk stratification, and longitudinal disease assessment. Yet tissue-based profiling has major limitations in pediatric neuro-oncology, particularly for deep-seated, eloquent, or surgically hazardous tumors and when repeat sampling is impractical. For primary CNS tumors, cerebrospinal fluid is generally more informative than plasma because it is anatomically closer to the tumor and more enriched for tumor-derived material. This narrative review summarizes current and emerging applications of cerebrospinal fluid in pediatric neuro-oncology, from conventional staging to molecular diagnosis, methylation-based classification, measurable residual disease detection, pharmacodynamic monitoring, and relapse surveillance. We discuss the biological rationale for cerebrospinal fluid analysis, major pre-analytical and technical determinants of assay performance, and the strengths and limitations of key analyte classes, including cytology, circulating tumor cells, cell-free DNA, RNA, extracellular vesicles, proteins, and metabolites. We also summarize how these approaches are being applied across major pediatric central nervous system tumor entities. Cerebrospinal fluid liquid biopsy is unlikely to replace tissue or imaging, but is increasingly positioned to complement both in precision pediatric neuro-oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen…
- Clinical-Academical Department of Laboratory Medicine, Pathology, and Genetics, "University Medical Center" Corporate Fund, 010000 Astana, Kazakhstan.
ORCID-Profile: Aidos Bolatov, Mirgul Bayanova
Förderung
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Bolatov, A., Zhakupov, A., Sapargaliyeva, M., Abdikadirova, A., Xu, X., & Bayanova, M. (2026). Cerebrospinal Fluid in Pediatric Neuro-Oncology: Molecular Diagnosis, Disease Monitoring, and Clinical Translation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27115010
Vancouver
Bolatov A, Zhakupov A, Sapargaliyeva M, Abdikadirova A, Xu X, Bayanova M. Cerebrospinal Fluid in Pediatric Neuro-Oncology: Molecular Diagnosis, Disease Monitoring, and Clinical Translation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27115010
BibTeX
@article{Bolatov2026,
author = {Bolatov, Aidos and Zhakupov, Askhat and Sapargaliyeva, Malika and Abdikadirova, Aizhan and Xu, Xingzhi and Bayanova, Mirgul},
title = {Cerebrospinal Fluid in Pediatric Neuro-Oncology: Molecular Diagnosis, Disease Monitoring, and Clinical Translation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27115010}
}
EUVIMED